Free shipping on all orders over $ 500

Palivizumab

Cat. No. M24841

All AbMole products are for research use only, cannot be used for human consumption.

Palivizumab Structure
Synonym:

MEDI 493

Size Price Availability Quantity
1mg USD 260 In stock
5mg USD 830 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Palivizumab (MEDI 493) is a humanized respiratory syncytial virus monoclonal antibody, reduces respiratory syncytial virus (RSV) infection. Palivizumab can bind to RSV F protein with a Kd value of 1.4 nM.

Chemical Information
CAS Number 188039-54-5
Storage Store at ≤ -20℃ for 24 months. Avoid repeated freeze-thaw cycles.
References

[1] Luis Garegnani, et al. Cochrane Database Syst Rev. Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children

[2] Manuel Sánchez Luna, et al. Paediatr Respir Rev. Expert consensus on palivizumab use for respiratory syncytial virus in developed countries

[3] Georgiana Georgescu, et al. Expert Opin Biol Ther. Palivizumab: where to from here?

[4] A B Russell. Hosp Med. Palivizumab: an overview

[5] L J Scott, et al. Drugs. Palivizumab

Related RSV Products
Ribavirin

Ribavirin (ICN-1229) is an antiviral agent used to study severe RSV infections, hepatitis C virus infections, and other viral infections.

Presatovir

Presatovir is a novel, orally bioavailable RSV fusion inhibitor, against a wide range of RSV A and B clinical isolates (mean EC50 = 0.43 nM).

RSV604 (A-60444)

RSV604 (A-60444) is a cell-permeable, non-cytotoxic (CC50 >50 μM) benzodiazepine derivative that is reported to target respiratory syncytial virus (RSV) nucleoprotein (N), with a Kd of 1.6 μM. RSV604 displays submicromolar activity against numerous clinical isolates of both the A and B subtypes of RSV (average EC50s=0.8 μM).

VV116 hydrobromide

VV116 (JT001) hydrobromide is an orally active nucleoside antiviral agent against SARS-CoV-2 and respiratory syncytial virus (RSV) infection.

Nirsevimab

Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with modified Fc region, which can prolong its half-life. Nirsevimab has an affinity for RSV-B with an Kd value of 1.5 nM. Nirsevimab can be used for RSV research.

  Catalog
Abmole Inhibitor Catalog




Keywords: Palivizumab, MEDI 493 supplier, RSV, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.